Children and SARS-CoV-2.

Bogunovic, Dusan; Merad, Miriam

Bogunovic, Dusan; Merad, Miriam.

Bogunovic D; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center of Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological sci
Merad M; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological science, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: miram.merad@mssm.edu.

Cell Host Microbe ; 29(7): 1040-1042, 2021 07 14.

Article in English | MEDLINE | ID: covidwho-1309194

ABSTRACT

ABSTRACT

A previously immune-naive world population is experiencing natural infection with SARS-CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory disorder primarily impacts children. Herein, we discuss known clinical and biological features of SARS-CoV-2 in children and reflect on currently identified immune features and discuss what remains unknown.

Subject(s)

COVID-19/immunology; COVID-19/physiopathology; Child; Hospitalization; Humans; Immunity; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Child / Humans Language: English Journal: Cell Host Microbe Journal subject: Microbiology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google